HAE - Haemonetics Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue886,116908,832910,373
Cost of Revenue507,622502,918475,955
Gross Profit378,494405,914434,418
Operating Expenses
Research Development37,55644,96554,187
Selling General and Administrative301,726312,496334,250
Non Recurring58,59392,3955,441
Total Operating Expenses---
Operating Income or Loss-19,381-43,94240,540
Income from Continuing Operations
Total Other Income/Expenses Net-8,095-9,474-9,375
Earnings Before Interest and Taxes-27,476-53,41631,165
Interest Expense---
Income Before Tax-27,476-53,41631,165
Income Tax Expense-1,2082,16314,268
Minority Interest---
Net Income From Continuing Ops-26,268-55,57916,897
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-26,268-55,57916,897
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-26,268-55,57916,897